Related Experiment Video
Updated: May 27, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Tailored therapy for rheumatic disease within reach]
Lisa G M van Baarsen1, Beatrijs M Lodde, Paul P Tak
1Academisch Medisch Centrum, afd. Klinische Immunologie en Reumatologie, Amsterdam, the Netherlands. p.p.tak@amc.uva.nl
Abstract:
Personalised medicine has the potential to increase therapeutic effectiveness, reduce side effects and lower cost. This approach has recently taken off in oncology where different malignancies may be treated with specific drugs based on genetic biomarkers or other tumour characteristics. This type of tailored therapy could also be developed for immune-mediated inflammatory disease, for which rheumatoid arthritis (RA) may serve as a prototype. While novel treatments are able to halt or even prevent disease progression, not all RA patients respond, and stratification of patient groups is needed. The identification of biomarkers predictive of the clinical response to specific treatments in subsets of patients may soon become reality in a variety of diseases.
Insights
Personalised medicine offers tailored treatments for better effectiveness and fewer side effects. Identifying biomarkers for rheumatoid arthritis (RA) and other immune-mediated diseases is key to optimizing patient response.
Area of Science:
- Biomedical science
- Pharmacogenomics
- Immunology
Context:
- Personalised medicine is revolutionizing oncology by tailoring treatments based on genetic biomarkers and tumor characteristics.
- Rheumatoid arthritis (RA) serves as a potential model for applying personalised medicine principles to immune-mediated inflammatory diseases.
- Current novel treatments for RA can halt disease progression, but patient response varies significantly.
Purpose:
- To explore the potential of personalised medicine in immune-mediated inflammatory diseases, using rheumatoid arthritis as a prototype.
- To highlight the need for patient stratification in RA treatment based on predictive biomarkers.
- To discuss the future development of tailored therapies for various diseases.
Summary:
- Personalised medicine aims to enhance therapeutic effectiveness, minimize side effects, and reduce healthcare costs.
- The abstract discusses the successful application of personalised medicine in oncology and its potential for immune-mediated inflammatory diseases like RA.
- Identifying biomarkers predictive of treatment response is crucial for stratifying RA patients and optimizing therapeutic outcomes.
Impact:
- Personalised medicine can lead to more effective and safer treatments for patients with immune-mediated inflammatory diseases.
- Biomarker discovery will enable precise patient stratification, improving treatment efficacy in RA and other conditions.
- This approach promises to transform the management of complex diseases by enabling tailored therapeutic strategies.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis III: Medical Management
Drug Therapy
Antianxiety Medications
